vs
CapsoVision, Inc（CV）与迈心诺（MASI）财务数据对比。点击上方公司名可切换其他公司
迈心诺的季度营收约是CapsoVision, Inc的105.0倍（$371.5M vs $3.5M）。迈心诺净利率更高（-27.0% vs -223.9%，领先196.9%）。迈心诺自由现金流更多（$50.9M vs $-5.7M）
CapsoVision, Inc.是一家医疗科技企业，专注研发、生产先进胶囊内窥镜系统及配套诊断解决方案，旗下非侵入式胃肠道成像产品供应全球多地的医院、消化科诊所及医疗专业人员，助力提升消化道疾病检测准确率与患者诊疗体验。
迈心诺（Masimo Corporation）是总部位于美国加利福尼亚州尔湾的健康科技及消费电子企业，核心产品包括面向医院及家用场景的患者监护设备、无创传感器及配套软件平台，同时也布局了消费级音频和可穿戴设备赛道。
CV vs MASI — 直观对比
营收规模更大
MASI
是对方的105.0倍
$3.5M
净利率更高
MASI
高出196.9%
-223.9%
自由现金流更多
MASI
多$56.6M
$-5.7M
损益表 — Q3 2025 vs Q3 2026
| 指标 | | |
|---|---|---|
| 营收 | $3.5M | $371.5M |
| 净利润 | $-7.9M | $-100.4M |
| 毛利率 | 54.1% | 62.1% |
| 营业利润率 | -226.7% | 22.5% |
| 净利率 | -223.9% | -27.0% |
| 营收同比 | — | -26.4% |
| 净利润同比 | — | -1124.5% |
| 每股收益（稀释后） | $-0.17 | $-1.84 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CVMASI
| Q3 25 | $3.5M | $371.5M | ||
| Q2 25 | $3.3M | $370.9M | ||
| Q1 25 | — | $372.0M | ||
| Q4 24 | — | $600.7M | ||
| Q3 24 | — | $504.6M | ||
| Q2 24 | — | $496.3M | ||
| Q1 24 | — | $492.8M | ||
| Q4 23 | — | $548.9M |
净利润CVMASI
| Q3 25 | $-7.9M | $-100.4M | ||
| Q2 25 | $-4.6M | $51.3M | ||
| Q1 25 | — | $-170.7M | ||
| Q4 24 | — | $-349.6M | ||
| Q3 24 | — | $9.8M | ||
| Q2 24 | — | $16.0M | ||
| Q1 24 | — | $18.9M | ||
| Q4 23 | — | $33.9M |
毛利率CVMASI
| Q3 25 | 54.1% | 62.1% | ||
| Q2 25 | 54.6% | 62.9% | ||
| Q1 25 | — | 62.9% | ||
| Q4 24 | — | 40.7% | ||
| Q3 24 | — | 52.2% | ||
| Q2 24 | — | 51.3% | ||
| Q1 24 | — | 49.0% | ||
| Q4 23 | — | 47.9% |
营业利润率CVMASI
| Q3 25 | -226.7% | 22.5% | ||
| Q2 25 | -140.3% | 17.4% | ||
| Q1 25 | — | 21.0% | ||
| Q4 24 | — | -59.8% | ||
| Q3 24 | — | 6.0% | ||
| Q2 24 | — | 5.7% | ||
| Q1 24 | — | 6.9% | ||
| Q4 23 | — | 8.0% |
净利率CVMASI
| Q3 25 | -223.9% | -27.0% | ||
| Q2 25 | -139.5% | 13.8% | ||
| Q1 25 | — | -45.9% | ||
| Q4 24 | — | -58.2% | ||
| Q3 24 | — | 1.9% | ||
| Q2 24 | — | 3.2% | ||
| Q1 24 | — | 3.8% | ||
| Q4 23 | — | 6.2% |
每股收益（稀释后）CVMASI
| Q3 25 | $-0.17 | $-1.84 | ||
| Q2 25 | $-2.02 | $0.94 | ||
| Q1 25 | — | $-3.12 | ||
| Q4 24 | — | $-6.54 | ||
| Q3 24 | — | $0.18 | ||
| Q2 24 | — | $0.29 | ||
| Q1 24 | — | $0.35 | ||
| Q4 23 | — | $0.63 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $312.3M |
| 总债务越低越好 | — | $559.1M |
| 股东权益账面价值 | $20.4M | $810.0M |
| 总资产 | $25.7M | $1.8B |
| 负债/权益比越低杠杆越低 | — | 0.69× |
8季度趋势，按日历期对齐
现金及短期投资CVMASI
| Q3 25 | — | $312.3M | ||
| Q2 25 | — | $149.6M | ||
| Q1 25 | — | $130.8M | ||
| Q4 24 | — | $177.6M | ||
| Q3 24 | — | $158.5M | ||
| Q2 24 | — | $129.6M | ||
| Q1 24 | — | $157.6M | ||
| Q4 23 | — | $163.0M |
总债务CVMASI
| Q3 25 | — | $559.1M | ||
| Q2 25 | — | $613.7M | ||
| Q1 25 | — | $651.0M | ||
| Q4 24 | — | $765.2M | ||
| Q3 24 | — | $772.6M | ||
| Q2 24 | — | $781.6M | ||
| Q1 24 | — | $876.0M | ||
| Q4 23 | — | $906.0M |
股东权益CVMASI
| Q3 25 | $20.4M | $810.0M | ||
| Q2 25 | $-139.0M | $1.0B | ||
| Q1 25 | — | $946.4M | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | — | $1.4B | ||
| Q1 24 | — | $1.4B | ||
| Q4 23 | — | $1.4B |
总资产CVMASI
| Q3 25 | $25.7M | $1.8B | ||
| Q2 25 | $9.5M | $2.4B | ||
| Q1 25 | — | $2.3B | ||
| Q4 24 | — | $2.6B | ||
| Q3 24 | — | $3.1B | ||
| Q2 24 | — | $2.9B | ||
| Q1 24 | — | $3.0B | ||
| Q4 23 | — | $3.0B |
负债/权益比CVMASI
| Q3 25 | — | 0.69× | ||
| Q2 25 | — | 0.59× | ||
| Q1 25 | — | 0.69× | ||
| Q4 24 | — | 0.73× | ||
| Q3 24 | — | 0.53× | ||
| Q2 24 | — | 0.57× | ||
| Q1 24 | — | 0.64× | ||
| Q4 23 | — | 0.66× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-5.7M | $56.8M |
| 自由现金流经营现金流 - 资本支出 | $-5.7M | $50.9M |
| 自由现金流率自由现金流/营收 | -160.5% | 13.7% |
| 资本支出强度资本支出/营收 | 0.3% | 1.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $191.0M |
8季度趋势，按日历期对齐
经营现金流CVMASI
| Q3 25 | $-5.7M | $56.8M | ||
| Q2 25 | $-9.5M | $69.4M | ||
| Q1 25 | — | $31.1M | ||
| Q4 24 | — | $50.5M | ||
| Q3 24 | — | $25.6M | ||
| Q2 24 | — | $74.5M | ||
| Q1 24 | — | $45.8M | ||
| Q4 23 | — | $77.1M |
自由现金流CVMASI
| Q3 25 | $-5.7M | $50.9M | ||
| Q2 25 | $-9.6M | $65.6M | ||
| Q1 25 | — | $28.5M | ||
| Q4 24 | — | $46.0M | ||
| Q3 24 | — | $16.9M | ||
| Q2 24 | — | $66.9M | ||
| Q1 24 | — | $37.6M | ||
| Q4 23 | — | $66.2M |
自由现金流率CVMASI
| Q3 25 | -160.5% | 13.7% | ||
| Q2 25 | -289.0% | 17.7% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 7.7% | ||
| Q3 24 | — | 3.3% | ||
| Q2 24 | — | 13.5% | ||
| Q1 24 | — | 7.6% | ||
| Q4 23 | — | 12.1% |
资本支出强度CVMASI
| Q3 25 | 0.3% | 1.6% | ||
| Q2 25 | 2.1% | 1.0% | ||
| Q1 25 | — | 0.7% | ||
| Q4 24 | — | 0.7% | ||
| Q3 24 | — | 1.7% | ||
| Q2 24 | — | 1.5% | ||
| Q1 24 | — | 1.7% | ||
| Q4 23 | — | 2.0% |
现金转化率CVMASI
| Q3 25 | — | — | ||
| Q2 25 | — | 1.35× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.61× | ||
| Q2 24 | — | 4.66× | ||
| Q1 24 | — | 2.42× | ||
| Q4 23 | — | 2.27× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
